Nuclein, LLC is an Austin, Texas-based company founded in 2017 with a vision to enable simple, affordable, rapid, and accurate testing for everyone. Its DASH® Rapid PCR System runs the FDA-cleared and CLIA-waived DASH® SARS-CoV-2 & Flu A/B Test and delivers lab-quality, point-of-care PCR results in 15 minutes. With a speed that is typically only available with antigen tests, the DASH® Rapid PCR System was designed to offer low-cost, sensitive and specific results, with robust multiplexing across various sample types, and requires less than one minute of hands-on time. Nuclein has raised approximately $50 million to date, led by private equity firm Trinity Investors. In 2023, Nuclein merged with Minute Molecular Diagnostics, Inc., a Northwestern University spin-out that initially developed the DASH System.
Company Details
- Employees
- 59
- Founded
- -
- Address
- Austin, Tx, Us
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Website
- nuclein.com
- Keywords
- Austin.
- HQ
- Austin, TX
Nuclein Questions
Nuclein's website is nuclein.com
Nuclein's LinkedIn profile is https://www.linkedin.com/company/nucleindx
Nuclein has
59 employees.
View email and phone details for 59
employees at Nuclein.
Nuclein's industry is
Medical Equipment Manufacturing
Nuclein's top competitors are
Orchard,
Pattern Bioscience,
Backd Business Funding,
Cesiumastro,
Fox Robotics,
Closinglock,
Made In,
Wiz,
Saronic Technologies,
Curative.
Nuclein's categories are Medical Equipment Manufacturing
Nuclein's founding year is 2017
